专题：Autoimmune and Inflammatory Disorders

This cluster of papers focuses on the association between neutrophilic dermatoses, such as Pyoderma Gangrenosum and Sweet's Syndrome, and inflammatory bowel diseases. It covers various aspects including clinical features, treatment strategies, pathophysiology, and potential links with autoinflammatory skin disorders.
最新文献
Acute febrile neutrophilic dermatosis in the setting of pembrolizumab in a patient with nonsmall cell lung cancer

article Full Text OpenAlex

Dupilumab-Induced Generalized Lichen Planus: A Case Report

article Full Text OpenAlex

Spatiotemporal transcriptomics deciphered neutrophil-activated interleukin-36 as driver and effective therapeutic target in Sweet syndrome

article Full Text OpenAlex

Lichen planus pigmentosus inversus after Pfizer-BioNTech COVID-19 vaccination: A rare case report

article Full Text OpenAlex

Symmetrical Drug‐Related Intertriginous and Flexural Exanthema Following Amoxicillin‐Clavulanate in a Patient With Chronic Obstructive Pulmonary Disease

article Full Text OpenAlex

Persistent Liver Manifestations in Allopurinol-Induced Sweet’s Syndrome: An Uncommon Case Report

article Full Text OpenAlex

Analysis of preoperative predictors for pouchitis after surgery for ulcerative colitis: A multicentre retrospective study of the clinical outcome of surgery for ulcerative colitis in Japan ( COSUC study)

article Full Text OpenAlex

[Spontaneous cervical swelling syndrome].

article Full Text OpenAlex

Silicone Granulomas: The Good, the Bad, the Ugly

article Full Text OpenAlex

A Rare Presentation of Late Latent Syphilis With Alopecia and Polyarticular Joint Pain in a 17-Year-old Teenager

article Full Text OpenAlex

近5年高被引文献
Crohn's disease

review Full Text OpenAlex 355 FWCI388.44105769

Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease

article Full Text OpenAlex 349 FWCI125.38608721

ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease

article Full Text OpenAlex 219 FWCI77.31891282

ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment

article Full Text OpenAlex 216 FWCI235.25303494

Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments

review Full Text OpenAlex 194 FWCI42.64010559

Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study

article Full Text OpenAlex 184 FWCI46.3809161

Inflammatory Bowel Disease

review Full Text OpenAlex 179 FWCI63.9504972

Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

article Full Text OpenAlex 169 FWCI44.08735432

Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)

article Full Text OpenAlex 127 FWCI64.11065333

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease

article Full Text OpenAlex 120 FWCI131.3040195